Check the background of this firm on FINRA's BrokerCheck.

Leigh Baldwin & Co.

112 Albany Street, Cazenovia, NY 13035 | Phone: (315) 655-2964 Toll Free: 1-800-659-8044

Check the background of this firm on FINRA's BrokerCheck.

Diamonds and Dogs

1/14/15

Blackberry Limited (BBRY)

Blackberry is looking sweet today, up 29.66% to $12.59. The cellular company saw its shares pop after a rumor from Reuters that Samsung recently approached the smartphone maker regarding a takeover. Samsung proposed an initial price range of $13.35 to $15.49 per share, which represents a premium of 38 percent to 60 percent, valuing the deal at around $6-7.5 billion. Samsung management stated that the deal was being discussed in order to have access to Blackberry's patent portfolio. Shares of Blackberry climbed nearly $3.00 today to a new 52-week high of $12.63 intraday.

Flamel Technologies SA (FLML)

Flamel is going up in flames today, down 37.68% to $11.51. The specialty pharmaceutical company saw its shares fall after news that the FDA has approved Fresenius Kabi's NDA for neostigmine methylsulfate, a drug which Flamel currently markets as Bloxiverz. The Company is in discussions with regulatory and legal counsel to evaluate options that will minimize the potential competitive impact of Fresenius Kabi's NDA approval. The possible competition from Fresenius is scaring off investors today, with shares of Flamel falling nearly $7.00. 

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.